Michelle L. VanLith

437 total citations
6 papers, 360 citations indexed

About

Michelle L. VanLith is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michelle L. VanLith has authored 6 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michelle L. VanLith's work include Glycosylation and Glycoproteins Research (5 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Michelle L. VanLith is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Michelle L. VanLith collaborates with scholars based in United States. Michelle L. VanLith's co-authors include Michael A. Hollingsworth, Richard M. Tempero, Sandra Gendler, Gerald J. Rowse, Keita Morikane, Surinder K. Batra, Sanjukta Deb, Marie E. Sutherlin, Ananya Choudhury and Subhash C. Chauhan and has published in prestigious journals such as The Journal of Immunology, Oncogene and International Immunology.

In The Last Decade

Michelle L. VanLith

6 papers receiving 353 citations

Peers

Michelle L. VanLith
Liying Jiang United States
Sandra Klausing Germany
Carina Olsson Switzerland
Bram ten Cate Netherlands
A. Maija Kissonerghis United Kingdom
IFC McKenzie Australia
Laura Hutchins United States
Antje Danielczyk Germany
Marta Pérez-Garay Spain
Liying Jiang United States
Michelle L. VanLith
Citations per year, relative to Michelle L. VanLith Michelle L. VanLith (= 1×) peers Liying Jiang

Countries citing papers authored by Michelle L. VanLith

Since Specialization
Citations

This map shows the geographic impact of Michelle L. VanLith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle L. VanLith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle L. VanLith more than expected).

Fields of papers citing papers by Michelle L. VanLith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle L. VanLith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle L. VanLith. The network helps show where Michelle L. VanLith may publish in the future.

Co-authorship network of co-authors of Michelle L. VanLith

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle L. VanLith. A scholar is included among the top collaborators of Michelle L. VanLith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle L. VanLith. Michelle L. VanLith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Moniaux, Nicolas, Christophe Némos, Bruno M. Schmied, et al.. (2006). The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene. 25(23). 3247–3257. 68 indexed citations
2.
Kohlgraf, Karl G., Andrew J. Gawron, Michiyo Higashi, et al.. (2004). Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1). Cancer Immunology Immunotherapy. 53(12). 1068–1084. 28 indexed citations
3.
VanLith, Michelle L.. (2002). MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses. International Immunology. 14(8). 873–882. 15 indexed citations
4.
Kohlgraf, Karl G., et al.. (2002). Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines. Cancer Immunology Immunotherapy. 51(6). 327–340. 14 indexed citations
5.
Rowse, Gerald J., Richard M. Tempero, Michelle L. VanLith, Michael A. Hollingsworth, & Sandra Gendler. (1998). Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.. PubMed. 58(2). 315–21. 182 indexed citations
6.
Tempero, Richard M., Michelle L. VanLith, Keita Morikane, et al.. (1998). CD4+ Lymphocytes Provide MUC1-Specific Tumor Immunity In Vivo That Is Undetectable In Vitro and Is Absent in MUC1 Transgenic Mice. The Journal of Immunology. 161(10). 5500–5506. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liying Jiang Breakdown of academic impact, for papers by Sandra Klausing Breakdown of academic impact, for papers by Carina Olsson Breakdown of academic impact, for papers by Bram ten Cate Breakdown of academic impact, for papers by A. Maija Kissonerghis Breakdown of academic impact, for papers by IFC McKenzie Breakdown of academic impact, for papers by Laura Hutchins Breakdown of academic impact, for papers by Antje Danielczyk Breakdown of academic impact, for papers by Marta Pérez-Garay
Rankless by CCL
2026